{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["82(4)"],"submitter":["Wong A"],"journal":["Journal of acquired immune deficiency syndromes (1999)"],"pagination":["e47-e49"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6830961"],"repository":["biostudies-literature"],"pubmed_title":["Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations."],"pmcid":["PMC6830961"],"pubmed_authors":["Hepler D","Rodgers A","Mallolas J","Johnson M","Pozniak A","Teal V","DeJesus E","Sklar P","Badshah C","Kumar S","Molina JM","Goldstein D","Hwang C","Teppler H","Wong A","Hanna GJ"],"additional_accession":[]},"is_claimable":false,"name":"Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations.","description":null,"dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Dec","modification":"2026-04-18T15:22:15.212Z","creation":"2025-04-06T02:09:23.401Z"},"accession":"S-EPMC6830961","cross_references":{"pubmed":["31425317"],"doi":["10.1097/QAI.0000000000002153"]}}